
Stephen E. Jones
Examiner (ID: 2262, Phone: (571)272-1762 , Office: P/2842 )
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2843, 2842, 2817 |
| Total Applications | 2057 |
| Issued Applications | 1739 |
| Pending Applications | 89 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18672939
[patent_doc_number] => 20230310391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/993868
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993868 | COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF | Nov 22, 2022 | Pending |
Array
(
[id] => 18269914
[patent_doc_number] => 20230091156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/899272
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899272 | METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS | Aug 29, 2022 | Pending |
Array
(
[id] => 18286296
[patent_doc_number] => 20230101768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD TO TREAT MANGANESE TOXICITY AND MANGANESE-INDUCED PARKINSONISM IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 17/819620
[patent_app_country] => US
[patent_app_date] => 2022-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819620 | METHOD TO TREAT MANGANESE TOXICITY AND MANGANESE-INDUCED PARKINSONISM IN HUMANS | Aug 12, 2022 | Pending |
Array
(
[id] => 18221879
[patent_doc_number] => 20230060873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOUNDS AND METHODS FOR FORMING ION CHANNELS IN BIOLOGICAL MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 17/881038
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881038 | COMPOUNDS AND METHODS FOR FORMING ION CHANNELS IN BIOLOGICAL MEMBRANES | Aug 3, 2022 | Pending |
Array
(
[id] => 18221879
[patent_doc_number] => 20230060873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOUNDS AND METHODS FOR FORMING ION CHANNELS IN BIOLOGICAL MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 17/881038
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881038 | COMPOUNDS AND METHODS FOR FORMING ION CHANNELS IN BIOLOGICAL MEMBRANES | Aug 3, 2022 | Pending |
Array
(
[id] => 18180409
[patent_doc_number] => 20230041138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => TREATMENT OF HIS HYPORESPONDERS
[patent_app_type] => utility
[patent_app_number] => 17/873009
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873009 | TREATMENT OF HIS HYPORESPONDERS | Jul 24, 2022 | Pending |
Array
(
[id] => 20341871
[patent_doc_number] => 12465586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Inhibitors of glucosylceramide synthase
[patent_app_type] => utility
[patent_app_number] => 17/865195
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13454
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17865195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/865195 | Inhibitors of glucosylceramide synthase | Jul 13, 2022 | Issued |
Array
(
[id] => 18003419
[patent_doc_number] => 20220362185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/860498
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860498 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS | Jul 7, 2022 | Pending |
Array
(
[id] => 18877363
[patent_doc_number] => 20240000732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => ANTI-MYCOBACTERIAL DRUGS
[patent_app_type] => utility
[patent_app_number] => 17/854360
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854360 | Anti-mycobacterial drugs | Jun 29, 2022 | Issued |
Array
(
[id] => 18091213
[patent_doc_number] => 20220409554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ASCORBIC ACID AND QUINONE COMPOUND FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/806689
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806689 | ASCORBIC ACID AND QUINONE COMPOUND FOR CANCER TREATMENT | Jun 12, 2022 | Pending |
Array
(
[id] => 18829577
[patent_doc_number] => 20230398101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => Co-agents as Therapy Against Anaerobic Pathogens
[patent_app_type] => utility
[patent_app_number] => 17/836959
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836959 | Co-agents as Therapy Against Anaerobic Pathogens | Jun 8, 2022 | Pending |
Array
(
[id] => 17928193
[patent_doc_number] => 20220323318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMPOSITION AND METHOD FOR REDUCING DEMINERALIZATION OF TEETH
[patent_app_type] => utility
[patent_app_number] => 17/824816
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824816 | COMPOSITION AND METHOD FOR REDUCING DEMINERALIZATION OF TEETH | May 24, 2022 | Abandoned |
Array
(
[id] => 19909223
[patent_doc_number] => 12285408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Methods and compositions for the treatment of snake bite
[patent_app_type] => utility
[patent_app_number] => 17/744502
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20190
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744502 | Methods and compositions for the treatment of snake bite | May 12, 2022 | Issued |
Array
(
[id] => 18107950
[patent_doc_number] => 20230000830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHODS FOR TREATING INJURY ASSOCIATED WITH EXPOSURE TO AN ALKYLATING SPECIES
[patent_app_type] => utility
[patent_app_number] => 17/735378
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735378 | METHODS FOR TREATING INJURY ASSOCIATED WITH EXPOSURE TO AN ALKYLATING SPECIES | May 2, 2022 | Abandoned |
Array
(
[id] => 17805649
[patent_doc_number] => 20220257484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => WHOLE MOUTH MALADOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/728246
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728246 | WHOLE MOUTH MALADOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS | Apr 24, 2022 | Pending |
Array
(
[id] => 19930292
[patent_doc_number] => 12303485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Arsinothricin and methods of treating infections using arsinothricin
[patent_app_type] => utility
[patent_app_number] => 17/696267
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 33
[patent_no_of_words] => 8305
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696267 | Arsinothricin and methods of treating infections using arsinothricin | Mar 15, 2022 | Issued |
Array
(
[id] => 20172957
[patent_doc_number] => 12391689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Synthesis of key intermediate of KRAS G12C inhibitor compound
[patent_app_type] => utility
[patent_app_number] => 17/689741
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 96
[patent_no_of_words] => 28342
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/689741 | Synthesis of key intermediate of KRAS G12C inhibitor compound | Mar 7, 2022 | Issued |
Array
(
[id] => 18034560
[patent_doc_number] => 20220378775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/681560
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681560 | OPHTHALMIC COMPOSITION | Feb 24, 2022 | Pending |
Array
(
[id] => 17640566
[patent_doc_number] => 20220168304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHODS FOR TREATING CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/650846
[patent_app_country] => US
[patent_app_date] => 2022-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650846
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650846 | METHODS FOR TREATING CYSTIC FIBROSIS | Feb 11, 2022 | Abandoned |
Array
(
[id] => 18056453
[patent_doc_number] => 20220387539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHODS OF TREATING MUSCLE CRAMPING AND RELATED COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/571884
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571884 | METHODS OF TREATING MUSCLE CRAMPING AND RELATED COMPOSITIONS | Jan 9, 2022 | Abandoned |